Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H41F2N5O |
Molecular Weight | 489.6441 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@H](N[C@H]1CCC2=C(C1)C(F)=CC(F)=C2)C(=O)NC3=CN(C=N3)C(C)(C)CNCC(C)(C)C
InChI
InChIKey=VFCRKLWBYMDAED-REWPJTCUSA-N
InChI=1S/C27H41F2N5O/c1-7-8-23(32-20-10-9-18-11-19(28)12-22(29)21(18)13-20)25(35)33-24-14-34(17-31-24)27(5,6)16-30-15-26(2,3)4/h11-12,14,17,20,23,30,32H,7-10,13,15-16H2,1-6H3,(H,33,35)/t20-,23-/m0/s1
Molecular Formula | C27H41F2N5O |
Molecular Weight | 489.6441 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:41:04 UTC 2023
by
admin
on
Sat Dec 16 05:41:04 UTC 2023
|
Record UNII |
QZ62892OFJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
636518
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1770916
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
CD-151
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
DB12005
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
1290543-63-3
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
QZ62892OFJ
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
865773-15-5
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
46224413
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
Nirogacestat
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
100000174650
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
C82383
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
10404
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY | |||
|
DTXSID60235679
Created by
admin on Sat Dec 16 05:41:04 UTC 2023 , Edited by admin on Sat Dec 16 05:41:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
FREE ASSAY
REVERSIBLE
IC50
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
Cellular assay using HEK293 cell line is 7.7 nM (0.34 nM free) for notch intracellular domain (NICD) inhibition
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
||||
Biological Half-life | PHARMACOKINETIC |
|